Related Experiment Video
Updated: May 11, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
18 F-FDG PET/MRI in Multiple System Atrophy-Parkinsonian Type (MSA-P).
Faizullah Mashriqi1, Alessandro di Rocco2, Ana M Franceschi1
1Department of Radiology, Neuroradiology Division.
This case study highlights a patient with a progressive movement disorder, diagnosed as multiple system atrophy, parkinsonian type (MSA-P). Advanced imaging confirmed the diagnosis, aiding in understanding this rare neurodegenerative condition.
Area of Science:
- Neuroscience
- Radiology
- Neurology
Background:
- Multiple system atrophy (MSA) is a rare, sporadic neurodegenerative disorder.
- It is characterized by autonomic dysfunction, parkinsonism, and cerebellar ataxia.
- Parkinsonian type (MSA-P) predominantly presents with parkinsonian features.
Purpose of the Study:
- To present a clinical case of multiple system atrophy, parkinsonian type (MSA-P).
- To correlate clinical presentation with advanced neuroimaging findings.
- To emphasize the diagnostic utility of 18F-FDG PET/MRI in MSA-P.
Main Methods:
- Clinical case presentation of a 64-year-old woman with a 4-year history of progressive movement disorder.
- DaTScan imaging to evaluate for Parkinsonian syndrome.
- 18F-FDG PET/MRI to assess brain metabolism and structure.
Main Results:
- Patient exhibited freezing of gait, discoordination, orthostatic symptoms, and urinary incontinence.
- DaTScan was abnormal, consistent with Parkinsonian syndrome.
- 18F-FDG PET/MRI revealed decreased uptake in bilateral putamina, putaminal atrophy, the putaminal rim sign, and central T2* hypointensity.
Conclusions:
- The combined clinical and imaging findings strongly support a diagnosis of MSA-P.
- 18F-FDG PET/MRI is valuable for diagnosing MSA-P, showing characteristic patterns of putaminal degeneration.
- Early and accurate diagnosis is crucial for managing MSA-P and its associated symptoms.
More Related Videos
10:02Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT
Published on: May 2, 2012
09:03Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
Published on: October 22, 2019
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET